Cluster of differentiation 38 monoclonal antibody therapy in the treatment of multiple myeloma: a systematic review and meta-analysis
CD38 monoclonal antibodies enhance the depth of response and prolong progression-free survival in multiple myeloma, with an acceptable safety profile, supporting their integration into treatment algorithms.
Authors
- Zhen-jun Zhu
- Zhi-Zhong Tian
- Yan-Jun Guo
- Xiao-Fen Zhang
Institutions
- Affiliated Hospital of Taishan Medical University (CN)
- Xinxiang Central Hospital (CN)
- Shandong First Medical University (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-02-12
- DOI
- https://doi.org/10.3389/fphar.2025.1687718
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00